TITLE

Comparison of Azathioprine, Cyclophosphamide, and Gold in Treatment of Rheumatoid Arthritis

AUTHOR(S)
Currey, H. L. F.; Harris, J.; Mason, R. M.; Woodland, J.; Beveridge, T.; Roberts, C. J.; Vere, D. W.; Dixon, A. St. J.; Davies, J.; Owen-Smith, B.
PUB. DATE
September 1974
SOURCE
British Medical Journal;9/28/1974, Vol. 3 Issue 5934, p763
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111842

 

Related Articles

  • Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. Berry, H.; Lilyanage, S.P.; Barnes, R.A.; Berger, L.A.; Evans, S. // British Medical Journal;5/1/1976, Vol. 1 Issue 6017, p1052 

    Focuses on the use of azathioprine and penicillamine for the treatment of rheumatoid arthritis in London, England. Comparison on the efficacy and toxicity between azathioprine and penicillamine; Side effects of penicillamine drug; Effectivity of the drugs.

  • NEW PRODUCTS.  // Drug Topics;3/22/2004, Vol. 148 Issue 6, p98 

    Reports on Salix Pharmaceuticals Ltd.'s launching of the immunosupressive agent Azasan (azathioprine) for the treatment of rheumatoid arthritis and related diseases.

  • Treatment of severe rheumatoid arthritis . Wright, Verna // British Medical Journal (Clinical Research Edition);2/15/1986, Vol. 292 Issue 6518, p431 

    Examines the treatment of severe rheumatoid arthritis. Symptoms of the disease; Development of steroid osteoporosis with crush fractures; Description of azathioprine.

  • Oral gold for rheumatoid arthritis. Wright, V. // British Medical Journal (Clinical Research Edition);10/6/1984, Vol. 289 Issue 6449, p858 

    Focuses on the efficacy of oral gold in the form of Auranofin for the treatment of rheumatoid arthritis. Toxicity of the oral gold; Benefits and drawbacks of the treatment; Comparison on the beneficial effects between oral gold and hydroxychloroquine.

  • New Hope When Old Drugs Fail. KG; Harrar, Sari; Caruso, David; Foley, Denise; Gault, Kevin; Kiser, Sherry; Matus, Jordan; Riddle, Judith Springer; Tennesen, Michael // Prevention;Dec2002, Vol. 54 Issue 12, p157 

    Discusses the use of cyclophosphamide chemotherapy as treatment for rheumatoid arthritis. How the cancer drug shocks the immune system.

  • A clinical and economic review of disease-modifying antirheumatic drugs. Gabriel, S.E.; Coyle, D.; Moreland, L.W. // PharmacoEconomics;Jul2001, Vol. 19 Issue 7, p715 

    Rheumatoid arthritis is one of the most common chronic systemic inflammatory diseases, affecting approximately 1% of the adult population. Disease-modifying antirheumatic drugs (DMARDs) have been the mainstay of treatment for rheumatoid arthritis when combined with physical therapy and aspirin...

  • Azathioprine.  // Reactions Weekly;8/20/2011, Issue 1365, p9 

    The article describes the case of a 49-year-old woman with rheumatoid arthritis and acquired haemophilia who developed myelosuppression while receiving treatment with azathioprine.

  • Azathioprine-induced shock. Cunningham, T.; Barraclough, D.; Muirden, K. // British Medical Journal (Clinical Research Edition);9/26/1981, Vol. 283 Issue 6295, p823 

    Examines the acute hypersensitivity reactions caused by azathioprine in patients with rheumatoid arthritis. Side-effects of the drug; Use of antihistamines for treatment; Detection of gastroenteritis.

  • Vasculitis and the dental team. Mills, John // Vital (17417503);Fall2013, Vol. 10 Issue 4, p29 

    The article discusses auto-immune disease primary systemic vasculitis (PSV). It informs about anti-neutrophil cytoplasmic antibody associated with vasculitis including Wegener's Granulomatosis, Microscopic Polyangiitis, and Churg Strauss syndrome. It states that immune-suppressing drugs such as...

  • Antineoplastics/immunosuppressants.  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p15 

    The article describes the clinical cases of four elderly patients who developed primary central nervous system (CNS) lymphoma and malignant melanoma while under a treatment regiment composed of azathioprine, mycophenolate mofetil, prednisone, methotrexate, cyclophosphamide and/or rituximab. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics